Cover Image

Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting

Abstract Background Antiemetic effects and safety of granisetron or palonosetron alone and in combination with a corticosteroid against chemotherapy-induced nausea and vomiting (CINV) were retrospectively evaluated in patients with Hodgkin lymphoma receiving adriamycin, bleomycin, vinblastine, and d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mayako Uchida (Author), Tsutomu Nakamura (Author), Kojiro Hata (Author), Hiroyuki Watanabe (Author), Yasuo Mori (Author), Koji Kato (Author), Kenjiro Kamezaki (Author), Katsuto Takenaka (Author), Motoaki Shiratsuchi (Author), Keiko Hosohata (Author), Toshihiro Miyamoto (Author), Koichi Akashi (Author)
Format:	Book
Published:	BMC, 2018-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy
by: Dhurjoti Prosad Bhattacharjee, et al.
Published: (2010)

Cost-utility analysis of palonosetron in the antiemetic regimen for cisplatin-containing highly emetogenic chemotherapy in Japan
by: Munenobu Kashiwa, et al.
Published: (2019)

Granisetron was more Effective than Ondansetron as Antiemetic in Ovarian Cancer Patients: a Randomized Controlled Trial
by: Hanif Reza, et al.
Published: (2023)

Comparison of Antiemetic Effects of Ondansetron, Granisetron and Tropisetron in Treatment of Acute Emesis Caused By Cisplatin/Paclitaxel Chemotherapy
by: Taner Turan, et al.
Published: (2016)

Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies
by: Cabanillas Stanchi KM, et al.
Published: (2019)

Clinician preference and comparison of the efficacy of ondansetron, granisetron, and palonosetron in preventing chemotherapy-induced nausea and vomiting among children receiving moderate or highly emetogenic chemotherapy
by: Rohan Bansal, et al.
Published: (2023)

Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (house musk shrew)
by: John A Rudd, et al.
Published: (2016)

Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)
by: Hisanori Shimizu, et al.
Published: (2018)

Comparison of Antiemetic Effects of Ondansetron Granisetron and Tropisetron For Acute Emesis In Ovarian Cancer Patients Receiving Chemotherapy With Paclitaxel and Carboplatin
by: Taner Turan, et al.
Published: (2007)

Comparison of IV granisetron and IV palonosetron on hemodynamics and sensory and motor block after spinal anesthesia with hyperbaric bupivacaine in patients undergoing abdominal hysterectomy
by: Jasmeen Choudhary, et al.
Published: (2019)

Management of postoperative nausea and vomiting: focus on palonosetron
by: Neil A Muchatuta, et al.
Published: (2008)

Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective study
by: Yoshinori Wakasugi, et al.
Published: (2019)

Update on the management of chemotherapy-induced nausea and vomiting – focus on palonosetron
by: Zhou M, et al.
Published: (2015)

Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetron
by: Lorusso V
Published: (2016)

Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report
by: Camille Cotteret, et al.
Published: (2020)

Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma
by: Min Hu, et al.
Published: (2023)

Management of acute and delayed chemotherapy-induced nausea and vomiting: role of netupitant–palonosetron combination
by: Janicki PK
Published: (2016)

Efficacy of the combination use of aprepitant and palonosetron for improving nausea in various moderately emetogenic chemotherapy regimens
by: Naohisa Yoshida, et al.
Published: (2019)

Prospective randomized trial with Palonosetron verses ondensetron for postoperative nausea and vomitting in general surgical population
by: Meenal Agarwal, et al.
Published: (2016)

Comparison of ondansetron, tropisetron, and palonosetron for the prevention of postoperative nausea and vomiting after middle ear surgery
by: Ahmet Aydin, MD, et al.
Published: (2019)

Adding aprepitant to palonosetron does not decrease carboplatin-induced nausea and vomiting in patients with gynecologic cancer
by: Yuko Watanabe, et al.
Published: (2021)

Higher dose of palonosetron versus lower dose of palonosetron plus droperidol to prevent postoperative nausea and vomiting after eye enucleation and orbital hydroxyapatite implant surgery: a randomized, double-blind trial
by: Hu X, et al.
Published: (2017)

Clinical profile and outcome of classical Hodgkin lymphoma treated with ABVD protocol at Homi Bhabha Cancer Hospital Varanasi
by: NIKITA SINGH, et al.
Published: (2022)

Utilization of Natural Polymer in the Preparation of Oral Jelly of Granisetron
by: Zahraa Mohammed Kadhim, et al.
Published: (2019)

An Evidence Practice Gap in Antiemetic Prescription with Chemotherapy
by: Chepsy C-Philip, et al.
Published: (2015)

Netupitant/palonosetron (NEPA; Akynzeo®) combination in prevention of the nausea and vomiting in patients with breast cancer receiving anthracyclinbased chemotherapy
by: A. G. Kedrova, et al.
Published: (2023)

A randomized study to compare palonosetron with ondansetron for prevention of postoperative nausea and vomiting following middle ear surgeries
by: Shubhangi Sharma, et al.
Published: (2019)

Concomitant palonosetron ameliorates cisplatin-induced nephrotoxicity, nausea, and vomiting: a retrospective cohort study and pharmacovigilance analysis
by: Miho Takemura, et al.
Published: (2022)

The effect of intraoperative antiemetics on postoperative nausea and vomiting in patients receiving intrathecal morphine for elective caesarean deliveries
by: Marcelo Epsztein Kanczuk, et al.
Published: (2022)

Influence of serotonin on the analgesic effect of granisetron on temporomandibular joint arthritis
by: Riina Kallikorm, et al.
Published: (2004)

Antiemetic prescribing patterns for post-operative surgical patients
by: Van N Tran1, et al.
Published: (2019)

Role of ganaton in antiemetic therapy. New treatment capacities
by: A. V. Snegovoy, et al.
Published: (2014)

Effect of Educational Program on Prophylactic Antiemetics Prescribing Practice
by: Zaid M.A Yousif, et al.
Published: (2019)

Pharmacovigilance Evaluation of Bendamustine-related Skin Disorders using the Japanese Adverse Drug Event Report Database
by: Mayako Uchida, et al.
Published: (2021)

Research Progress on the Antiemetic Effect of Traditional Chinese Medicine Against Chemotherapy-Induced Nausea and Vomiting: A Review
by: Yao-Zhong Zhao, et al.
Published: (2022)

Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients
by: Ghufran salah ahmed, et al.
Published: (2023)

Influência do CD 20 na refratariedade do linfoma de Hodgkin clássico ao tratamento inicial com o esquema ABVD, no Ceará, Brasil Influence of CD 20 antigen expression in the refractoriness of classical Hodgkin lymphoma in the first line treatment with ABVD protocol in Ceará state, Brazil
by: Rogério Pinto Giesta, et al.
Published: (2009)

Population pharmacokinetic analysis of transdermal granisetron in healthy Chinese and Caucasian volunteers
by: Jiayu Li, et al.
Published: (2023)

Comparison of dexamethasone, granisetron and haloperidol in prevention of postoperative nausea and vomiting following laparoscopic surgeries: A prospective, double-blinded study
by: Shikha Sharma, et al.
Published: (2019)

Evaluating the antiemetic administration consistency to prevent chemotherapy-induced nausea and vomiting with the standard guidelines: a prospective observational study
by: Vazin A, et al.
Published: (2017)